Sign In
NewsRadar

Masabi lands €2.9 million from m8 Capital

2 November 2011 16:05
By Tornado Staff

Masabi, a UK developer of mobile phone ticketing technology, has completed a €2.9 million Series B round of funding with its existing shareholder, the mobile technology fund m8 Capital.

Masabi offers mobile ticketing technology for the transport sector. Its applications turn mobile phones into personalized ticket machines which allow people to securely purchase and display tickets on almost any mobile phone, not just smartphones. Once people have bought a ticket, their phone can be easily scanned at the gate or by a train guard. This means travelers can avoid ticket machines and queues.

Masabi works in partnership with transport systems integrators, including thetrainline.com and Atos, and is deployed with operators including Virgin Trains, Cross Country Trains, First TransPennine Express, First Hull Trains, Chiltern Railways and others. The latest funding round will support the company’s deployments in the UK. It will also be used for the development of new service features, including NFC technology, and for expansion into new markets, particularly the US.

The company secured its Series A funding round of €1.5 million in September 2010.



Related stories
Purple WiFi pulls in €4.3M for social login and location analytics
Mobile messaging app Jongla receives €3.4 million investment
DelfMEMS gets fresh funds for its RF MEMS switches
Shopgate receives funding for its mobile commerce platform
Last.fm founder Breidenbrücker joins 42matters team


Up
Data


20,276
Tech investments
From our Online Data Service
13,080
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Jul 27N/AInternet commerce
Jul 27€55.0MInternet commerce
Jul 24€1.0MBiotechnology
Jul 23€33.0MBiotechnology
Jul 23€37.0MInternet commerce
Jul 22€2.2MBiotechnology
Jul 22N/ABiotechnology

For information on Europe's most extensive database on technology funding click here!

Events


BIO-Europe 2015
November 2 - 4, 2015

CONNECTIONS Europe
November 10 - 11, 2015


Press Releases


Jul 22
Wilson Therapeutics
wilson therapeutics announces the appointment of dr. carl bjartmar ...

Jul 16
Immunocore Ltd
immunocore secures $320 million (£205 million) in europe’s largest ...

Jul 15
Mailjet
iris capital leads series b round for email service provider mailjet

Jul 15
Credit Benchmark
credit benchmark raises $20m in series b financing led by balderton...

Jul 10
Autifony Therapeutics
autifony therapeutics extends series a with £8 million for hearing ...





About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.